Presenter: Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately, the evidence shows these medications don’t seem to have a clinically important effect and do have some harms. Have a listen as we give you…
CFP Podcast: Perennial post-examination surprises
BS Medicine Episode #586: It’s time to challenge penicillin allergy labels
BS Medicine Episode #585: PREMIUM – Beta-blockers after an MI and respiratory specialists for COPD
Presenter(s):
Dr. James McCormack Dr. Mike Allan Dr. Tina Korownyk
Please provide any additional comments (optional).